An independent newsroom of one. Every story is cross-referenced across multiple trusted Indian publications, scored, and rewritten without ads, bias, or noise.

News

Politics
Business
Sports
Technology
World
Entertainment

About

How verification works
Saved stories

Legal

Privacy Policy
Terms of Use
Corrections Policy
Contact & Tips

Transparency

No advertising or sponsored content
Every claim links back to its sources
Open-source under the MIT licence
AI cross-verifies before publishing

Built in IndiaDesigned & engineered by Roshhellwett, with the help of Claude & other tools.

Home

Swipe

Saved

SBI funds Sun Pharma’s Organon deal — India Verified

Back to all news

Business
SBI funds Sun Pharma’s Organon deal

Business9 June 2026 at 03:42 pmQuick read

SBI funds Sun Pharma’s Organon deal

Credibility score80 / 100

LowModerateHigh

2sources verified

SBI is funding Sun Pharma's deal. The deal is worth $12 billion. SBI joins other financiers.

AI Credibility Analysis

The score falls in the 70-89 band as it is based on a single named source, Mint Business, with some specific data and details about the deal, but lacks multiple authoritative sources for full verification.

Original Sources

Mint
The Economic Times

How this story was built

Cross-Referenced

2 Sources

Unbiased AI

⚡

Auto-Published

SBI funds Sun Pharma’s Organon deal

How this story was built

Related stories

US Stock Futures Decline

ASK Property Fund eyes housing debt bet

India exports GI-tagged Tezpur Litchi to Dubai